Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In a 2025 study of tirzepatide vs
As of 2026, the investigational drug Retatrutide remains in the advanced stages of clinical development, specifically within its comprehensive Phase 3 TRIUMPH program
Patients receiving tirzepatide 10 mg or 15 mg achieved mean weight reductions of 9.3 kg and 11.2 kg respectively over 40 weeks, demonstrating that tirzepatide's weight loss efficacy remains substantial when added to existing metformin therapy
Although these data show a favorable riskbenefit profile for GLP-1RA, there are differences between individual drugs with respect to their effect on cardiorenal outcomes in the separate trials
Ozempic usually leads to less weight loss compared to Wegovy since it is given at lower doses, with most people seeing about 5%-10% reduction
US$ 25.69
US$ 29.37
US$ 24.64
US$ 26.85
US$ 21.50
US$ 24.26
US$ 21.69
